Dawn-bio ApS: Financial statements 2023
CVR: 43849662
Source: annual report 2023, Danish Business Authority
13/02/2023 – 31/12/2023
Dawn-bio ApS (CVR 43849662) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -561,652 and a net result of DKK -785,330. Equity in the 2023 report amounted to DKK -745,330. The company had 1 employee in the financial year.
- Gross Profit
- DKK -561,652
- Profit/Loss
- DKK -785,330
- Equity
- DKK -745,330
- Total Assets
- DKK 3,413,475
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of February 13, 2023, Alok Javali is registered as director of Dawn-bio ApS.
As of February 13, 2023, is registered as an owner of Dawn-bio ApS with an ownership share of 100%.
Dawn-bio ApS was founded on February 13, 2023.
About Dawn-bio ApS
Dawn-bio ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Peter Greiner and Alok Javali. The company is owned by dawn-bio GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -638,228 and a net result of DKK -1,121,090 compared with DKK -1,568,059 the year before. Equity in the 2025 report amounted to DKK -3,434,479.